Aclaris Therapeutics Inc (NASDAQ: ACRS) Just Learned Something New After This Week’s 4.24% Gain
Aclaris Therapeutics Inc (NASDAQ:ACRS)’s traded shares stood at 1.45 million during the last session, with the company’s beta value hitting 0.23. At the close of